SURMODICS INC — Director's Dealing 2021

Mar 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2021-03-01

Reporting Person: Maharaj Gary R (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-01	Common Stock	S	3001	$51.8623	Disposed	165712	Direct
2021-03-01	Common Stock	S	999	$52.6731	Disposed	164713	Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020.

F2: Reflects the weighted average price of 3,001 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on March 1, 2021 with sale prices ranging from $51.50 to $52.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Includes 459 shares acquired through the Employee Stock Purchase Plan for the phase ending 02/26/2021.

F4: Reflects the weighted average price of 999 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on March 1, 2021 with sale prices ranging from $52.52 to $52.92 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.